Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 2
2005 1
2008 5
2009 1
2010 5
2011 3
2012 2
2013 5
2014 1
2015 3
2016 3
2017 2
2018 2
2019 3
2020 4
2021 1
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States.
Perofsky AC, Huddleston J, Hansen C, Barnes JR, Rowe T, Xu X, Kondor R, Wentworth DE, Lewis N, Whittaker L, Ermetal B, Harvey R, Galiano M, Daniels RS, McCauley JW, Fujisaki S, Nakamura K, Kishida N, Watanabe S, Hasegawa H, Sullivan SG, Barr IG, Subbarao K, Krammer F, Bedford T, Viboud C. Perofsky AC, et al. Among authors: kishida n. medRxiv [Preprint]. 2023 Oct 3:2023.10.02.23296453. doi: 10.1101/2023.10.02.23296453. medRxiv. 2023. PMID: 37873362 Free PMC article. Preprint.
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2.
Ohashi H, Hishiki T, Akazawa D, Kim KS, Woo J, Shionoya K, Tsuchimoto K, Iwanami S, Moriyama S, Kinoshita H, Yamada S, Kuroda Y, Yamamoto T, Kishida N, Watanabe S, Hasegawa H, Ebihara H, Suzuki T, Maeda K, Fukushi S, Takahashi Y, Iwami S, Watashi K. Ohashi H, et al. Among authors: kishida n. Antiviral Res. 2022 Sep;205:105372. doi: 10.1016/j.antiviral.2022.105372. Epub 2022 Jul 4. Antiviral Res. 2022. PMID: 35798223 Free PMC article.
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys.
Hashimoto M, Nagata N, Homma T, Maeda H, Dohi K, Seki NM, Yoshihara K, Iwata-Yoshikawa N, Shiwa-Sudo N, Sakai Y, Shirakura M, Kishida N, Arita T, Suzuki Y, Watanabe S, Asanuma H, Sonoyama T, Suzuki T, Omoto S, Hasegawa H. Hashimoto M, et al. Among authors: kishida n. Vaccine. 2022 Jul 29;40(31):4231-4241. doi: 10.1016/j.vaccine.2022.05.081. Epub 2022 Jun 6. Vaccine. 2022. PMID: 35691872 Free PMC article.
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants.
Miyamoto S, Arashiro T, Adachi Y, Moriyama S, Kinoshita H, Kanno T, Saito S, Katano H, Iida S, Ainai A, Kotaki R, Yamada S, Kuroda Y, Yamamoto T, Ishijima K, Park ES, Inoue Y, Kaku Y, Tobiume M, Iwata-Yoshikawa N, Shiwa-Sudo N, Tokunaga K, Ozono S, Hemmi T, Ueno A, Kishida N, Watanabe S, Nojima K, Seki Y, Mizukami T, Hasegawa H, Ebihara H, Maeda K, Fukushi S, Takahashi Y, Suzuki T. Miyamoto S, et al. Among authors: kishida n. Med. 2022 Apr 8;3(4):249-261.e4. doi: 10.1016/j.medj.2022.02.006. Epub 2022 Mar 4. Med. 2022. PMID: 35261995 Free PMC article.
Antiviral Susceptibilities of Avian Influenza A(H5), A(H7), and A(H9) Viruses Isolated in Japan.
Takashita E, Morita H, Nagata S, Shirakura M, Fujisaki S, Miura H, Takayama I, Arita T, Suzuki Y, Yamaoka M, Tanikawa T, Tsunekuni R, Mine J, Sakuma S, Uchida Y, Shibata A, Iwanaka M, Kishida N, Nakamura K, Kageyama T, Watanabe S, Hasegawa H; Influenza Virus Surveillance Group of Japan. Takashita E, et al. Among authors: kishida n. Jpn J Infect Dis. 2022 Jul 22;75(4):398-402. doi: 10.7883/yoken.JJID.2021.751. Epub 2021 Dec 28. Jpn J Infect Dis. 2022. PMID: 34980710 Free article.
Antibody-dependent enhancement of Marburg virus infection.
Nakayama E, Tomabechi D, Matsuno K, Kishida N, Yoshida R, Feldmann H, Takada A. Nakayama E, et al. Among authors: kishida n. J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S978-85. doi: 10.1093/infdis/jir334. J Infect Dis. 2011. PMID: 21987779 Free PMC article.
Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: Implications for vaccine dose interval.
Miyamoto S, Kuroda Y, Kanno T, Ueno A, Shiwa-Sudo N, Iwata-Yoshikawa N, Sakai Y, Nagata N, Arashiro T, Ainai A, Moriyama S, Kishida N, Watanabe S, Nojima K, Seki Y, Mizukami T, Hasegawa H, Ebihara H, Fukushi S, Takahashi Y, Maeda K, Suzuki T. Miyamoto S, et al. Among authors: kishida n. iScience. 2023 May 19;26(5):106694. doi: 10.1016/j.isci.2023.106694. Epub 2023 Apr 19. iScience. 2023. PMID: 37124417 Free PMC article.
Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019.
Takashita E, Ichikawa M, Morita H, Ogawa R, Fujisaki S, Shirakura M, Miura H, Nakamura K, Kishida N, Kuwahara T, Sugawara H, Sato A, Akimoto M, Mitamura K, Abe T, Yamazaki M, Watanabe S, Hasegawa H, Odagiri T. Takashita E, et al. Among authors: kishida n. Emerg Infect Dis. 2019 Nov;25(11):2108-2111. doi: 10.3201/eid2511.190757. Epub 2019 Nov 17. Emerg Infect Dis. 2019. PMID: 31436527 Free PMC article.
Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution.
Huddleston J, Barnes JR, Rowe T, Xu X, Kondor R, Wentworth DE, Whittaker L, Ermetal B, Daniels RS, McCauley JW, Fujisaki S, Nakamura K, Kishida N, Watanabe S, Hasegawa H, Barr I, Subbarao K, Barrat-Charlaix P, Neher RA, Bedford T. Huddleston J, et al. Among authors: kishida n. Elife. 2020 Sep 2;9:e60067. doi: 10.7554/eLife.60067. Elife. 2020. PMID: 32876050 Free PMC article.
A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023.
Takashita E, Fujisaki S, Morita H, Nagata S, Miura H, Matsuura Y, Yamamoto S, Chiba S, Inoue Y, Minami I, Yoshikawa S, Yamazaki S, Kishida N, Nakamura K, Shirakura M, Watanabe S, Hasegawa H. Takashita E, et al. Among authors: kishida n. Euro Surveill. 2023 Sep;28(39):2300501. doi: 10.2807/1560-7917.ES.2023.28.39.2300501. Euro Surveill. 2023. PMID: 37768560 Free PMC article.
52 results